LOGIN
Volume:7
Issue:10
Number:35
ISSN#:2563-5476
Meta-analysis
ACE Report #9456
Zoledronic Acid, alendronate, and risedronate reduce vertebral, nonvertebral, and hip fracture
How to Cite
OrthoEvidence. Zoledronic Acid, alendronate, and risedronate reduce vertebral, nonvertebral, and hip fracture. ACE Report. 2018;7(10):35. Available from: https://myorthoevidence.com/AceReport/Report/9456
Study Type:Meta analysis
OE Level Evidence:1
Journal Level of Evidence:N/A
Comparative efficacy of bisphosphonates in short-term fracture prevention for primary osteoporosis: a systematic review with network meta-analyses
Osteoporos Int. 2016 Nov;27(11):3289-3300Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
36 randomized controlled trials were included in this network meta-analysis to evaluate the comparative efficacy of different bisphosphonates in the management of osteoporosis. Nine different bisphosphonates were assessed in the included studies, with direct and indirect comparisons evaluated for vertebral fracture, nonvertebral fracture, hip fracture, wrist fracture, and any fracture. Zoledronic ...
To view the full report, start your 30-day free trial today
No credit card required
JOIN LOGIN Forgot Password?Not sure if you want to join OrthoEvidence?
Access this report without an Account.Success, an email containing a link to access this report has been sent to your inbox.
Explore some of our unlocked reports below!
.jpg)
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.
LEARN MOREFor Reprints and Permissions, click here
Please Login or Join to leave comments.